Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

254
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
254
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

892
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
892
Stimulants01:29

Stimulants

282
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
282
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

450
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
450
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

361
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
361

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are "race-neutral" lung volume prediction equations appropriate? A critical review of the contributions of anthropometric differences and socioeconomic factors to lung volumes.

The European respiratory journal·2026
Same author

Assessment of uranium with toxicological and radiological implications in potable water sources of the eastern region of Kumaun Himalaya, India.

Isotopes in environmental and health studies·2026
Same author

Water parks, vaping, COPD topics on team management, exacerbations, bronchoscopic therapies, lung transplantation, and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same author

Ability of Radiomics Versus Humans in Predicting First-Pass Effect After Endovascular Treatment in the ESCAPE-NA1 Trial.

Stroke (Hoboken, N.J.)·2026
Same author

Chronic obstructive pulmonary disease exacerbations for the academic hospitalist: an opportunity to learn and improve care.

Current opinion in pulmonary medicine·2025
Same author

Understanding radon behaviour in traditional Indian dwellings: Insights from a validated CFD study of a representative mud test house.

Environmental pollution (Barking, Essex : 1987)·2025

Related Experiment Video

Updated: Aug 24, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

262

Marijuana and the Lung: Evolving Understandings.

Manish Joshi1, Anita Joshi2, Thaddeus Bartter1

  • 1Pulmonary and Critical Care Division, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA; Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA.

The Medical Clinics of North America
|October 24, 2022
PubMed
Summary
This summary is machine-generated.

Marijuana

Keywords:
Cannabis smokingChronic obstructive pulmonary diseaseLung cancerMarijuana

More Related Videos

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface
07:05

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Published on: June 20, 2025

301
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

138

Related Experiment Videos

Last Updated: Aug 24, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

262
In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface
07:05

In vitro Cannabis Exposures of Lung Epithelial Cells at the Air-Liquid Interface

Published on: June 20, 2025

301
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

138

Area of Science:

  • Neuroscience and Pharmacology
  • Pulmonary Medicine

Background:

  • Cannabinoid receptors are widespread in the human brain, influencing nervous system functions.
  • Historical use of marijuana products is well-documented.

Purpose of the Study:

  • To explore the impacts of cannabinoids on diseases like pain and seizures.
  • To evaluate the respiratory and cognitive effects of marijuana use.

Main Methods:

  • Review of existing literature on cannabinoid receptor distribution.
  • Analysis of studies investigating marijuana's effects on the respiratory system and cognitive functions.

Main Results:

  • Cannabinoids influence symptoms such as pain and seizures.
  • Marijuana use is linked to bronchitis but not chronic obstructive pulmonary disease or lung cancer.
  • Potential for cognitive impairment and developmental brain effects exists.

Conclusions:

  • Cannabinoids have significant neurological effects, impacting conditions like pain and seizures.
  • While marijuana poses risks like bronchitis and potential cognitive impairment, it differs from tobacco regarding lung cancer and COPD.
  • Further research is needed to balance the therapeutic potential of marijuana with its risks, especially concerning the developing brain.